Literature DB >> 12544722

The initial phase of oral anticoagulation with warfarin in outpatients with deep venous thrombosis.

Walter Ageno1, Luigi Steidl, Carolina Ultori, Francesco Dentali, Chiara Marchesi, Valentina Mera, Alessandro Squizzato, Achille Venco.   

Abstract

Patients with deep venous thrombosis (DVT) treated out of hospital usually start warfarin with the recommended 5 mg loading dose and have their International Normalized Ratio (INR) test performed every 2-3 days. Thus, achievement of the therapeutic range may be more difficult than for inpatients, possibly resulting in extended duration of low molecular weight heparin (LMWH) treatment. We retrospectively examined the charts of 55 DVT outpatients (mean age, 61.4 years; 30 males) to assess the actual duration of LMWH treatment and to identify predictors of a slow achievement of the INR range. Thirty patients (54.4%) reached the therapeutic INR range and stopped LMWH within 7 days, and 25 patients (45.6%) had to continue for an average of 10.5 days. The latter group was significantly younger than the former (57 and 65 years, respectively; P = 0.039). Patients younger than 60 years old had an odds ratio for an extended treatment of 4.92 (P = 0.0057). Algorithms with different loading doses of warfarin according to age should be proposed for outpatient treatment of DVT. Copyright 2003 Lippincott Williams & Wilkins

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12544722     DOI: 10.1097/00001721-200301000-00003

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  2 in total

1.  Comparison of initial warfarin response in obese patients versus non-obese patients.

Authors:  Jessica L Wallace; Anne B Reaves; Elizabeth A Tolley; Carrie S Oliphant; Lydia Hutchison; Numan Abdulraman Alabdan; Christopher W Sands; Timothy H Self
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

2.  Effects of oral anticoagulation with various INR levels in deep vein thrombosis cases.

Authors:  Ufuk Yetkin; Ozalp Karabay; Hakan Onol
Journal:  Curr Control Trials Cardiovasc Med       Date:  2004-02-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.